Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study

被引:0
作者
Emma Houchen
Emil Loefroth
Raymond Schlienger
Clare Proudfoot
Stefano Corda
Sibasish Saha
Sarvesh K. Satwase
Rachel Studer
机构
[1] Novartis Ireland Ltd.,
[2] Novartis Sweden AB,undefined
[3] Novartis Pharma AG,undefined
[4] Novartis Healthcare Pvt. Ltd,undefined
[5] Medical and Knowledge Solutions,undefined
[6] Novartis Global Service Center,undefined
来源
Cardiology and Therapy | 2022年 / 11卷
关键词
Angiotensin-converting enzyme inhibitor; Angiotensin receptor blocker; Angiotensin receptor neprilysin inhibitor; Heart failure; Sacubitril/valsartan;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:113 / 127
页数:14
相关论文
共 91 条
  • [31] Chang C(undefined)undefined undefined undefined undefined-undefined
  • [32] Chang C(undefined)undefined undefined undefined undefined-undefined
  • [33] Song X(undefined)undefined undefined undefined undefined-undefined
  • [34] Nguyen A(undefined)undefined undefined undefined undefined-undefined
  • [35] Smith D(undefined)undefined undefined undefined undefined-undefined
  • [36] Choi M(undefined)undefined undefined undefined undefined-undefined
  • [37] Duffy C(undefined)undefined undefined undefined undefined-undefined
  • [38] Chang HY(undefined)undefined undefined undefined undefined-undefined
  • [39] Feng AN(undefined)undefined undefined undefined undefined-undefined
  • [40] Fong MC(undefined)undefined undefined undefined undefined-undefined